Evolution of kinase polypharmacology across HSP90 drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evolution of kinase polypharmacology across HSP90 drug discovery

Published:2021-10 Issue:10 Volume:28 Page:1433-1445.e3
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Antolin Albert A.^ORCID,Clarke Paul A.^ORCID,Collins Ian^ORCID,Workman Paul^ORCID,Al-Lazikani Bissan^ORCID

Funder

EU Framework Programme for Research and Innovation Marie Sklodowska-Curie Actions

Wellcome Trust

ACCIÓ

Cancer Research UK

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference72 articles.

1. Fragment growing to retain or alter the selectivity of anchored kinase hinge-binding fragments;Allen;Medchemcomm,2014

2. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity;Anastassiadis;Nat. Biotechnol.,2011

3. Polypharmacology: challenges and opportunities in drug discovery;Anighoro;J. Med. Chem.,2014

4. Computational polypharmacology analysis of the heat shock protein 90 interactome;Anighoro;J. Chem. Inf. Model.,2015

5. Polypharmacology in precision oncology: current applications and future prospects;Antolin;Curr. Pharm. Des.,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery;Expert Opinion on Drug Discovery;2024-07-14

2. A fluorescence‐based sensor for calibrated measurement of protein kinase stability in live cells;Protein Science;2024-05-27

3. Data-oriented protein kinase drug discovery;European Journal of Medicinal Chemistry;2024-05

4. Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite;Cell Chemical Biology;2024-05

5. Design and Synthesis of Novel 6,7‐Dihydrobenzo[d]isoxazol‐4(5H)‐one Derivatives Bearing 1,2,3‐Triazole Moiety as Potential Hsp90 Inhibitors and their Evaluation as Antiproliferative Agents;ChemistrySelect;2024-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3